MAPT and Alzheimer disease: In several neurodegenerative diseases such as Parkinson’s, frontotemporal dementia, dementia with Lewy bodies and AD, tau levels are highly elevated, which can be potentially used as a diagnosis and prognostic biomarker [53,54,55,56].